Abrdn Healthcare Investors (HQH) P/E Ratio History
UndervaluedTrading at 6.1x vs 5Y avg 9.3x · 43th percentile · Below historical baseline · Data 2015–2024
Loading P/E history...
P/E Ratio Analysis
As of June 29, 2026, Abrdn Healthcare Investors (HQH) trades at a price-to-earnings ratio of 6.1x, with a stock price of $21.63 and trailing twelve-month earnings per share of $4.50.
The current P/E is 35% below its 5-year average of 9.3x. Over the past five years, HQH's P/E has ranged from a low of 2.7x to a high of 25.1x, placing the current valuation at the 43th percentile of its historical range.
Compared to the Financial Services sector median P/E of 14.2x, HQH trades at a 57% discount to its sector peers. The sector includes 801 companies with P/E ratios ranging from 0.0x to 157.7x.
Relative to the broader market, HQH trades at a notable discount to the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our HQH DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
HQH Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
HQH P/E vs Peers
Closed-end funds and investment trusts peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $585M | 6.5Lowest | - | +275% | |
| $187M | 29.9 | 10.29 | +73% | |
| $4B | 11.2 | 1.16 | +59% | |
| $193B | 25.2 | 8.56 | +88% | |
| $159B | 18.9 | 0.14Best | +1684%Best | |
| $66B | 15.3 | 2.41 | +8% | |
| $125B | 32.1 | 3.87 | +837% | |
| $32B | 24.5 | - | -21% | |
| $27B | 32.4 | 7.66 | +171% | |
| $144B | 51.4 | 2.36 | +23% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
HQH Historical P/E Data (2015–2024)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2024 Q4 | - | $16.05 | $4.75 | 3.4x | -64% |
| FY2024 Q2 | Jun 30 2024 | $17.46 | $1.52 | 11.5x | +23% |
| FY2022 Q2 | - | $18.69 | $5.27 | 3.5x | -62% |
| FY2021 Q4 | Dec 31 2021 | $23.76 | $8.86 | 2.7x | -71% |
| FY2021 Q2 | Jun 30 2021 | $25.73 | $6.01 | 4.3x | -54% |
| FY2020 Q4 | - | $23.83 | $2.04 | 11.7x | +25% |
| FY2020 Q2 | - | $21.33 | $0.85 | 25.1x | +168% |
| FY2019 Q2 | Jun 30 2019 | $20.08 | $1.63 | 12.3x | +32% |
| FY2018 Q4 | Dec 31 2018 | $17.95 | $4.52 | 4.0x | -58% |
| FY2018 Q2 | Jun 30 2018 | $21.50 | $2.95 | 7.3x | -22% |
| FY2017 Q4 | Dec 31 2017 | $22.55 | $1.43 | 15.8x | +69% |
| FY2016 Q4 | Dec 31 2016 | $21.13 | $1.23 | 17.2x | +84% |
| FY2016 Q2 | - | $23.44 | $2.63 | 8.9x | -5% |
| FY2015 Q4 | - | $29.66 | $9.03 | 3.3x | -65% |
Average P/E for displayed period: 9.3x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
11+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
HQH — Frequently Asked Questions
Quick answers to the most common questions about buying HQH stock.
What is HQH's P/E ratio?
Abrdn Healthcare Investors (HQH) trailing twelve-month P/E ratio is 6.1x, based on TTM diluted EPS of $4.50. The 5-year average P/E is 9.3x and the historical range spans 2.7x to 25.1x.
Is HQH stock overvalued or undervalued?
HQH trades at 6.1x P/E, below its 5-year average of 9.3x. At the 43th percentile of its historical range (2.7x–25.1x), the stock is priced at a discount to its own history.
Is HQH stock expensive?
No, HQH is not expensive on a historical basis. The current P/E of 6.1x is below the 5-year average of 9.3x and sits at the 43th percentile of its valuation range.
What is HQH's historical P/E range?
Over the past 5 years, HQH's P/E ratio has ranged from 2.7x to 25.1x, with a median of 8.9x and an average of 9.3x. The current P/E of 6.1x places the stock at the 43th percentile of this range. Full historical data spans 2015–2024.
How does HQH's P/E compare to the S&P 500?
HQH trades at 6.1x P/E versus the S&P 500 median of 25.3x. The 76% discount to the market suggests lower growth expectations or perceived higher risk.
How does HQH's valuation compare to Financial Services peers?
Abrdn Healthcare Investors P/E of 6.1x compares to the Financial Services sector median of 14.2x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is HQH's PEG ratio?
HQH PEG ratio is N/A, based on a P/E of 6.1x and EPS growth of 211.4%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is HQH's earnings yield?
HQH earnings yield is 16.41%, the inverse of its 6.1x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.